Chemotherapy resistance is the major issue of choriocarcinoma. Apoptosis always is the ultimate outcome of chemotherapeutic drugs, which considered one of the reasons of resistance. We investigated the role of STAT3/NFIL3 signaling-inhibited apoptosis in chemotherapy resistance and whether Raddeanin A (RA) could be a new drug to 
suppressed-apoptosis (Rathore, McCallum, Varghese, Florea, & Büsselberg, 2017) . Importantly the high level of apoptosis was observed in methotrexate-resistant JEG-3 cells compared with parental cells (Shen et al., 2015) . Indeed, we also found that there were different levels of apoptosis variation in drug-resistant CC cells in preliminary experiment. Hence, we hypothesized that apoptosis inhibition may contribute to the development of drug resistance. NFIL3 (nuclear factor interleukin 3 regulated, also known as E4 binding protein 4, E4BP4) impacts many cellular processes and is widely expressed in human tissues, especially could highly induced by hCG treatment (Kashiwada, Pham, Pewe, Harty, & Rothman, 2011; Li, Liu, & Jo, 2011 ). Apoptosis plays a major role in development and tissue homeostasis (Fuchs & Steller, 2011; Lim, Yang, Bazer, & Song, 2017) .
NFIL3 could inhibits apoptosis in numerous settings from B-cells to motor neurons, which 50% undergo apoptosis (Ikushima et al., 1997) .
High-expression of NFIL3 in embryonic rat and chicken motor neurons that survive developmental pruning, while more than half of the motor neurons produced undergo programmed cell death (Raff et al., 1993) . In line with its ability to hinder cell death, NFIL3 has emerged as a novel survival factor in cancer. In the research of mechanisms in IL-10-mediared anti-inflammatory effect, it is found that NFIL3 is a key component of the STAT3-mediated anti-inflammatory mechanism (Smith et al., 2011) . Signal transducer and activator of transcription 3 (STAT3) belongs to STAT family of proteins. Constitutively active STAT3 mediates critical gene expression changes and molecular events that regulating cell growth and apoptosis (Turkson & Jove, 2000; Yang et al., 2012) . As a now validated anticancer drug target, the inhibitors of the STAT3 pathway as a novel approach to inducing cancer cell apoptosis and hence treating cancer patients (Niu et al., 2011; Zhang, Zhou, Gu, Yan, & Zhang, 2014) . But the clinical safety of these compound is not clear, investigation of new usage in traditional drugs is more popular.
Several traditional Chinese medicines are used for the treatment of tumors including gynecological carcinomas in China. Raddeanin A (RA) is an oleanane-type triterpenoid saponin extracted from the root of Anemone raddeana Regelm, a traditional Chinese medicinal herb (Luan et al., 2013) . The mainly functions of RA which once reported are developed to anti-inflammation and anti-tumor treatments (Guan et al., 2015) . Previous studies have also shown that RA induced apoptosis and inhibited invasion in human gastric cancer cells (Xue et al., 2013) . And in our preliminary studies, RA can suppress choriocarcinoma JEG-3 cells proliferation (unpublished data). More importantly, RA showed synergy with cisplatin in therapeutic effect in human hepatocellular carcinoma (Li et al., 2017) . However, its effect and mechanisms on drug resistance are still largely unknown. In this study, the possible mechanisms of resistance, and the inhibitory effects of RA on the reversal resistance of chemotherapeutics in CC were investigated.
| MATERIALS AND METHODS

| Drug and cells
Raddeanin A was obtained from National Institute for the Control of Pharmaceutical and Biological Products (Beijing, CN). The human choriocarcinoma JEG-3 cell line was laboratory-preserved which purchased from the American Type Culture Collection (ATCC, Manassas, VA) (Shi, Tan, Lu, Yang, & Zhang, 2014) . Anti-etoposide cell line named JEG-3/VP16 was purchased from the China Center for Type Culture Collection (Wuhan, China). Cells were cultured in DMEM-high glucose supplemented (Gibco, Rockford, IL) with 10% FBS (Gibco), 50 U/ml penicillin, and 50 µg/ml of streptomycin at 37°C in a 5% CO 2 atmosphere.
| Establishment of drug-resistant sublines
Methotrexate (MTX)-and fluorouracil (5-FU)-resistant variants were obtained by exposing parental cell line to stepwise increased MTX and 5-FU (Sigma, St. Louis, MO) concentrations by intermittent-and consecutive-feeding methods (Snow & Judd, 1991) . The JEG-3/MTX obtained by initially exposing JEG-3 from 0.001 to 10 µg/ml MTX until they achieved a growth rate like untreated cells. The JEG-3/5-FU was the same, whereas they exposed in the 5-FU concentration from 0.025 to 50 µg/ml.
| Cell proliferation assay
The inhibitory concentration 50% (IC 50 ) was explored with Cell 
| Flow cytometric analysis for apoptosis
To analyze cell apoptosis, cells with varies treatments were stained by propidium iodide (PI) and FITC-Annexin V as the Apoptosis Detection Kit (BD, Franklin Lakes, NJ) protocol, tested by Flow Cytometer (BD). The results analyzed by FlowJo software.
| TUNEL assay
The cell TUNEL assay was performed using Apoptosis Detection Kit 
| Transfection
The scramble, NFIL3 siRNA (5′-GAUGAGGGUGUAGUGGGCAAGU-CUU-3′) were synthesized by Ribobio (Guangzhou, CN). Cells were seeded in six-well plates with a density of 2 × 10 5 cells/well and transfected with siRNAs using the riboFECT™ CP (Ribobio,
Guangzhou, CN). The LV-STAT3-RNAi was provided by Open
Biosystems (RMM3981-97059843, clone ID TRCN0000071456).
The over-expression Lenti-OE™-STAT3 and Lenti-OE™-NFIL3 were provided by Genechem (Shanghai, CN), which transfected into cells for 48 hr.
| Luciferase reporter assay
The NFIL3 
| Co-immunoprecipitation
The total protein was lysed in RIPA lysis buffer, and then was incubated with anti-pSTAT3 or IgG as a negative control. Added to agarose shaken for 4 hr at 4°C and centrifuged for 5 min at 2,500g following.
The washed precipitation was suspended in SDS buffer with primary antibodies against p-STAT3 and NFIL3, used for Western blot analyses.
| Bioinformatic data mining
We downloaded GEO data of different resistant cells from GEO After repeated experiments, we found that the three sublines showed a low rate of apoptosis exposing chemotherapeutics using Flow cytometry 
| NFIL3 represses drug-induced apoptosis
In the procession of establishment of drug-resistant cells, NFIL3
protein level highly increased as cultivating generation (Figure 2a ) with chemotherapeutics. We hypothesized that NFIL3 related to the formation of drug resistance. To test it, cells transfected with NFIL3
siRNA was established. As the Figure 2b showed, the IC 50 of chemotherapeutics was significantly decreased in the siNFIL3 group compared with controls (mock group; p < 0.001). To study whether NFIL3 repressed chemotherapeutics-induced apoptosis in CC cells, TUNEL ( Figure 2c ) and Flow cytometry ( Figure 2d ) were used. The siNFIL3 group exposed in drugs for 24 hr, with a higher apoptosis rate than the NC-treated cells (p < 0.001).
| Activated STAT3 signaling enhances NFIL3 promoter activity
Aberrant IL-6/STAT3 signaling in cancer cells have emerged as a major mechanism for cancer initiation and development. IL-6 can induces STAT3 activation (Yu & Jove, 2004) , what is no exception in the drugresistant CC cells (Supplementary Figure S1 ). We performed a detailed analysis of the NFIL3 promoter in the NCBI database, and identified the main STAT3-binding sites (Figure 3a) . Luciferase reporter vectors containing wild type and mutant type were constructed and subjected to luciferase reporter assay. The relative luciferase activity was significantly decreased with transfection of shSTAT3, but it was increased by STAT3 overexpression and IL-6 stimulation ( Figure 3b ). 
| Co-expression of STAT3 and NFIL3 correlated with chemotherapy resistance
As the same of NFIL3, STAT3 was activated as cultivating generation 
| DISCUSSION
Preventing and reversing chemoresistance of choriocarcinoma have become one of the focuses of the present studies (Horowitz, Goldstein, & Berkowitz, 2017) . For the low-risk choriocarcinoma, methotrexate and fluorouracil are the first-line chemotherapy drugs in choriocarcinoma as monotherapy regimen, and liable to cause resistance. As the most vital regimen for high-risk, relapsing, and resistant choriocarcinoma, EMA-CO regimen involves etoposide which occurs multidrug resistance reported before (Shen et al., 2015) . In current study, the JEG-3/MTX, JEG-3/5-FU, and JEG-3/VP16 were used for resistance models. Caspase-cascade is a central part of cell apoptosis and regulated by various kinds of molecules, such as Bcl-2 family proteins (Fan, Han, Cong, & Liang, 2005; Ghavami et al., 2009) . Evidence suggests that some high dosage chemotherapy leads to caspase-independent cell death, but it remains unclear if toxicity to health cells may be a compromising factor in its effectiveness (Su, Yang, Xie, DeWitt, & Chen, 2016) . CC cells exhibit intrinsic resistance to chemotherapy drugs, often attributed to high endogenous expression of drug efflux transporters such as MDR1 and some acquired chemoresistance in them develop generations (Ikeda et al., 2012) . To combat both intrinsic and acquired chemoresistance, and thus prevent the eventual invincibility of cancer cells, it is important to solve the apoptosismediated chemoresistance. We observed the drug-resistant cells showed a low rate of apoptosis contrast to JEG-3 cells. Further the Caspase 3 were activated by chemotherapeutics, including Bcl-2 suppression, which indicated the cell apoptosis pathway. These results hinted us to stat with apoptosis issue for solving chemotherapy resistance.
As the survival factor, over-expression of NFIL3 in rat embryonic fibroblasts induced survival genes such as Bcl-2 expression and hindered caspase 3 induction preventing apoptosis (Weng et al., 2010) , which was indeed supported by our current finding that NFIL3 expression increased following the cell generations and strikingly related with Caspase 3 dependent apoptosis. In addition, siNFIL3 influenced the IC 50 value of the drug-resistant cells, which indicated NFIL3-inhibited apoptosis changed the chemoresistance.
This is the first study to evaluate the correlation of NFIL3 and chemoresistance. And the most important what we found was a novel factor influencing choriocarcinoma resistance, which as the potential target for drugs. However, there is no special inhibitor of NFIL3 and short of the direct-bonding compounds.
On the other hand, fortunately, using NCBI database, we learned that the STAT3 possible bind to NFIL3 promoter. Several studies had suggested that IL6/STAT3 pathway was closely associated with the CC cells proliferation (Liu, Gu, & Li, 2013) . IL-6 cytokine superfamilyinduced activation of STAT3 played a crucial role in induction of invasiveness of trophoblastic cells (Fitzgerald et al., 2005) . The expression of p-STAT3 was confirmed related with chemotherapeutic resistance in ovarian, hepatocellular, and neck cancers (Gu et al., 2010 which induced apoptosis including caspase 9 pathway (Shen et al., 2015) . Although further studies are necessary to address the unique resistance mechanism of each resistant cell line, our data allude to a possible mechanism by which STAT3/NFIL3 signaling axis may protect all kinds of drug-resistant cells from apoptosis of chemotherapy drugs.
It is short of big data of choriocarcinoma due to the difficulty in obtaining tissue samples. We analyzed the correlation of STAT3 and NFIL3 in different drug-resistant cells, including colon cancer, breast cancer, malignant melanoma etc. via GEO data. Despite the small sample sizes, the results all indicate the positive correlation of them, further verify our present study. In the predict molecular pathways, we found some interesting molecule related with both STAT3 and NFIL3 directly, such as CREB1 (cAMP responsive element binding protein 1) and NFKBIZ (NFKB inhibitor zeta), which hint that more research can be performed to investigate the regulatory network of STAT3/NFIL3 axis.
Fighting apoptosis is the principal mechanism of tumor cell to resisting death and is an important pointcut for the development of anticancer drugs. In human GC cells, RA can regulate the Bcl-2 family to induce apoptosis (Teng et al., 2016) . However, the research on CC In conclusion, our data support the hypothesis that STAT3/NFIL3 signaling axis-repressed apoptosis is a dominating driving factor responsible for chemotherapeutic resistance, which could be reversed by RA.
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